|
|
.
NPI Detail
NPI: 1003878539
Type: Organization
Taxonomy Code: 261QE0700X
End-Stage Renal Disease Facility
Ambulatory Health Care Facilities/End-Stage Renal Disease (ESRD) Treatment
1500 X XXXXXXX XXXXXX XX
ANN ARBOR, MI 481095000
Business phone: (XXX) XXX-XXXX
Mailing address phone: (XXX) XXX-XXXX
|
Click here for new NPI search.
|
2021 OPPS Part A Medicare Services Submitted NPI-1003878539*
OPPS Payment Method "A" - Services not paid under OPPS; uses a different fee schedule (e.g., ambulance, PT, mammography)
Top Level I HCPC Procedures
| Procedure | Description | Number Submitted | Medicare Payment |
| 85025
|
COMPLETE CBC W/AUTO DIFF WBC
|
XXXXX
|
$XXXXXX.XX
|
| 97110
|
THERAPEUTIC EXERCISES
|
XXXXX
|
$XXXXXXX.XX
|
| 80053
|
COMPREHEN METABOLIC PANEL
|
XXXXX
|
$XXXXXX.XX
|
| 97140
|
MANUAL THERAPY 1/> REGIONS
|
XXXXX
|
$XXXXXX.XX
|
Top Drugs Administered Other than Oral Method
| Procedure | Description | Number Submitted | Medicare Payment |
| J2704
|
Inj, propofol, 10 mg
|
XXXXXX
|
-
|
| J0585
|
Injection,onabotulinumtoxina
|
XXXXXX
|
$XXXXXX.XX
|
| J1756
|
Iron sucrose injection
|
XXXXXX
|
-
|
| J9271
|
Inj pembrolizumab
|
XXXXXX
|
$XXXXXXX.XX
|
| J0881
|
Darbepoetin alfa, non-esrd
|
XXXXXX
|
$XXXXXX.XX
|
| J9263
|
Oxaliplatin
|
XXXXXX
|
-
|
| J1569
|
Gammagard liquid injection
|
XXXXXX
|
$XXXXXXX.XX
|
| J9299
|
Injection, nivolumab
|
XXXXXX
|
$XXXXXXX.XX
|
| J8540
|
Oral dexamethasone
|
XXXXXX
|
-
|
| J2795
|
Ropivacaine hcl injection
|
XXXXXX
|
-
|
| J9267
|
Paclitaxel injection
|
XXXXXX
|
-
|
| J0185
|
Inj., aprepitant, 1 mg
|
XXXXXX
|
$XXXXXX.XX
|
| J9144
|
Daratumumab, hyaluronidase
|
XXXXX
|
$XXXXXXX.XX
|
| J9264
|
Paclitaxel protein bound
|
XXXXX
|
$XXXXXX.XX
|
| J0897
|
Denosumab injection
|
XXXXX
|
$XXXXXX.XX
|
| J3380
|
Injection, vedolizumab
|
XXXXX
|
$XXXXXX.XX
|
| J0878
|
Daptomycin injection
|
XXXXX
|
-
|
| J1447
|
Inj tbo filgrastim 1 microg
|
XXXXX
|
$XXXXX.XX
|
| J0131
|
Inj, acetaminophen (nos)
|
XXXXX
|
-
|
| J9312
|
Inj., rituximab, 10 mg
|
XXXXX
|
$XXXXXXX.XX
|
| J0588
|
Incobotulinumtoxin a
|
XXXXX
|
$XXXXXX.XX
|
| J1644
|
Inj heparin sodium per 1000u
|
XXXXX
|
-
|
| J1453
|
Fosaprepitant injection
|
XXXXX
|
$XXXXX.XX
|
| J3262
|
Tocilizumab injection
|
XXXXX
|
$XXXXXX.XX
|
| J9306
|
Injection, pertuzumab, 1 mg
|
XXXXX
|
$XXXXXX.XX
|
| J0256
|
Alpha 1 proteinase inhibitor
|
XXXXX
|
$XXXXXX.XX
|
| J1100
|
Dexamethasone sodium phos
|
XXXXX
|
-
|
| J2350
|
Injection, ocrelizumab, 1 mg
|
XXXXX
|
$XXXXXXX.XX
|
| J9176
|
Injection, elotuzumab, 1mg
|
XXXXX
|
$XXXXXX.XX
|
| J9047
|
Injection, carfilzomib, 1 mg
|
XXXXX
|
$XXXXXX.XX
|
Top HCPC Level II Procedures / Professional Services
| Procedure | Description | Number Submitted | Medicare Payment |
| G0463
|
Hospital outpt clinic visit
|
XXXXXX
|
$XXXXXXXX.XX
|
| G0378
|
Hospital observation per hr
|
XXXXX
|
-
|
* Medicare Part A utilization data is derived from the 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
|
